Skip to main content

Advertisement

Table 2 Correlation between variations in body composition and psychiatric symptoms after intragastric balloon (IGB) treatment (∆ for all variables)

From: Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

  BMI (kg/m2) Weight (kg) Waist (cm) Total fat (g) Total fat (%) Lean mass (g)
BDI r = 0.11
p = 0.48
r = 0.12
p = 0.46
r = 0.24
p = 0.14
r = 0.20
p = 0.26
r = 0.46
p = 0.008
r = −0.04
p = 0.81
HADS-depression r = 0.02
p = 0.87
r = 0.05
p = 0.75
r = 0.23
p = 0.16
r = −0.02
p = 0.89
r = 0.12
p = 0.50
r = 0.05
p = 0.77
HADS-anxiety r = 0.27
p = 0.084
r = 0.28
p = 0.08
r = 0.38
p = 0.017
r = 0.21
p = 0.22
r = 0.42
p = 0.014
r = 0.22
p = 0.21
  1. DXA dual-energy X-ray absorptiometry; BMI body mass index; BDI Beck Depression Inventory; HADS hospital anxiety and depression scale; HADS-D hospital anxiety and depression scale-depression; HADS-A hospital anxiety and depression scale-anxiety